|
NRAS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66420000400092E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97589999706827E-09 |
| Normal-vs-Stage2 |
1.846350E-02 |
| Normal-vs-Stage3 |
1.304040E-03 |
| Normal-vs-Stage4 |
5.076300E-03 |
| Stage1-vs-Stage2 |
5.547200E-01 |
| Stage1-vs-Stage3 |
2.573000E-01 |
| Stage1-vs-Stage4 |
7.015900E-02 |
| Stage2-vs-Stage3 |
8.755600E-01 |
| Stage2-vs-Stage4 |
5.804200E-01 |
| Stage3-vs-Stage4 |
5.834800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01310000388821E-08 |
| Normal-vs-AfricanAmerican |
5.094600E-01 |
| Normal-vs-Asian |
2.534000E-02 |
| Caucasian-vs-AfricanAmerican |
7.67080000000364E-05 |
| Caucasian-vs-Asian |
9.828200E-01 |
| AfricanAmerican-vs-Asian |
9.765600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58494999999981E-05 |
| Normal-vs-Female |
1.65900000403951E-08 |
| Male-vs-Female |
4.500400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.811900E-02 |
| Normal-vs-Age(41-60Yrs) |
7.84909999995698E-07 |
| Normal-vs-Age(61-80Yrs) |
5.7528999997114E-07 |
| Normal-vs-Age(81-100Yrs) |
1.787560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.200600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.570000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.137600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.185400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.129000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.062200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.079000E-03 |
| Normal-vs-Grade 2 |
1.15800002919997E-09 |
| Normal-vs-Grade 3 |
1.210970E-04 |
| Normal-vs-Grade 4 |
9.824500E-02 |
| Grade 1-vs-Grade 2 |
7.480200E-01 |
| Grade 1-vs-Grade 3 |
7.606200E-02 |
| Grade 1-vs-Grade 4 |
1.505690E-02 |
| Grade 2-vs-Grade 3 |
2.280500E-03 |
| Grade 2-vs-Grade 4 |
1.354020E-04 |
| Grade 3-vs-Grade 4 |
1.300180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71840319751482E-12 |
| Normal-vs-ccB subtype |
9.243800E-03 |
| ccA subtype-vs-ccB subtype |
2.48589999995996E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.06960000032264E-07 |
| Normal-vs-N1 |
2.024200E-01 |
| N0-vs-N1 |
5.976400E-01 |
|
|
